Leo Foundation's new CIO looks forward to life without MIFID II

At the start of October, a top member of Danske Capital's team swapped his job at the Danish banking group for the foundation that owns Danish drugmaker Leo Pharma. The limits of MIFID II are now a thing of the past, says Morten Stampe Christensen.

Morten Stampe Christensen, new CIO at Leo Foundation. Photo: LEO Foundation

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch